NO873423L - Fremgangsmaate for fremstilling av farmasoeytiske preparater - Google Patents

Fremgangsmaate for fremstilling av farmasoeytiske preparater

Info

Publication number
NO873423L
NO873423L NO873423A NO873423A NO873423L NO 873423 L NO873423 L NO 873423L NO 873423 A NO873423 A NO 873423A NO 873423 A NO873423 A NO 873423A NO 873423 L NO873423 L NO 873423L
Authority
NO
Norway
Prior art keywords
mentioned
nicorandil
acid
weight
base material
Prior art date
Application number
NO873423A
Other languages
English (en)
Norwegian (no)
Other versions
NO873423D0 (no
Inventor
Masato Azuma
Toshihiro Inoue
Yasuaki Kawano
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO873423D0 publication Critical patent/NO873423D0/no
Publication of NO873423L publication Critical patent/NO873423L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO873423A 1986-08-18 1987-08-14 Fremgangsmaate for fremstilling av farmasoeytiske preparater NO873423L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19249386 1986-08-18
JP19249286 1986-08-18
JP8027687 1987-04-01

Publications (2)

Publication Number Publication Date
NO873423D0 NO873423D0 (no) 1987-08-14
NO873423L true NO873423L (no) 1988-02-19

Family

ID=27303257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873423A NO873423L (no) 1986-08-18 1987-08-14 Fremgangsmaate for fremstilling av farmasoeytiske preparater

Country Status (18)

Country Link
US (1) US5211943A (cs)
EP (1) EP0260452B1 (cs)
KR (1) KR880002523A (cs)
CN (1) CN87105632A (cs)
AR (2) AR241513A1 (cs)
AT (1) ATA207887A (cs)
AU (1) AU7717587A (cs)
BE (1) BE1000477A3 (cs)
CS (1) CS601987A2 (cs)
DE (1) DE3782594T2 (cs)
DK (1) DK424987A (cs)
ES (1) ES2052528T3 (cs)
FI (1) FI873566L (cs)
GR (1) GR871267B (cs)
HU (1) HU200923B (cs)
NO (1) NO873423L (cs)
NZ (1) NZ221465A (cs)
PT (1) PT85543B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2886446B2 (ja) * 1994-03-03 1999-04-26 関西ペイント株式会社 塗膜保護用シート
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
KR100674108B1 (ko) * 1999-04-13 2007-01-26 히사미쓰 세이야꾸 가부시키가이샤 경피흡수형 제제
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
EP4370121A1 (en) 2021-07-10 2024-05-22 Auxilius Pharma Spolka Z Ograniczona Odpowiedzialnoscia Modified release nicorandil compound formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS60184010A (ja) * 1984-03-02 1985-09-19 Nitto Electric Ind Co Ltd 経皮投与用医薬製剤
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
JPH0627068B2 (ja) * 1984-09-22 1994-04-13 中外製薬株式会社 経皮薬剤
JPS61103840A (ja) * 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device

Also Published As

Publication number Publication date
US5211943A (en) 1993-05-18
CS601987A2 (en) 1990-08-14
AR240017A1 (es) 1990-01-31
DE3782594T2 (de) 1993-06-03
NZ221465A (en) 1989-12-21
ATA207887A (de) 1990-08-15
DE3782594D1 (de) 1992-12-17
EP0260452A1 (en) 1988-03-23
GR871267B (en) 1987-12-24
FI873566A0 (fi) 1987-08-18
AU7717587A (en) 1988-02-25
AR241513A1 (es) 1992-08-31
FI873566A7 (fi) 1988-02-19
DK424987D0 (da) 1987-08-14
BE1000477A3 (fr) 1988-12-20
KR880002523A (ko) 1988-05-09
FI873566L (fi) 1988-02-19
PT85543A (en) 1987-09-01
HU200923B (en) 1990-09-28
HUT45397A (en) 1988-07-28
NO873423D0 (no) 1987-08-14
ES2052528T3 (es) 1994-07-16
PT85543B (en) 1989-11-06
EP0260452B1 (en) 1992-11-11
CN87105632A (zh) 1988-03-30
DK424987A (da) 1988-02-19

Similar Documents

Publication Publication Date Title
AU712692B2 (en) Transdermal therapeutic systems containing crystallization inhibitors
JPH0460091B2 (cs)
US5716636A (en) Transdermal therapeutic system with acetylsalicylic acid in crystalline form as active substance
US20070264319A1 (en) Transdermal Antiemesis Delivery System, Method and Composition Therefor
NO873423L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
JP5622410B2 (ja) ケトプロフェン含有水性貼付剤
KR20180121352A (ko) 경피 흡수형 제제
RU1799272C (ru) Трансдермальна терапевтическа система и способ ее получени
US4837025A (en) Self-adhesive device for the percutaneous administration of an active ingredient
AU726537B2 (en) Plasters containing isosorbide dinitrate
WO2004112770A1 (ja) ツロブテロール含有貼付剤
JP7565034B2 (ja) 薬物の生体への吸収性に優れ、且つ、化学的安定性にも優れる医薬組成物
WO2004071499A1 (ja) ジクロフェナク含有貼付剤
JPS63246326A (ja) ニトログリセリンを含有する感圧性粘着テープまたはシートの製造方法
JP4237293B2 (ja) 経皮吸収型貼付剤
US20040081682A1 (en) Transdermal system (tds) that contain inhibitors of phosphodiesterase lV
JP3002492B2 (ja) 経皮吸収製剤
JP2004224701A (ja) 外用貼付剤
JPH03261722A (ja) 経皮吸収製剤
JPH11209270A (ja) 経皮吸収製剤
JP2003511407A (ja) 座瘡関連の病気の治療のためのアセチルサリチル酸の局所適用のための表面治療システム
JP3002491B2 (ja) 経皮吸収製剤
JPWO2005011669A1 (ja) 経皮投与用医薬組成物
JPH0386828A (ja) プラスター剤
WO2019167694A1 (ja) メチルフェニデート含有貼付剤